Worldwide Ebitda from 2010 to 2024

WWH Stock   359.50  0.50  0.14%   
Worldwide Healthcare's EBITDA is increasing over the years with stable fluctuation. Overall, EBITDA is expected to go to about 214.2 M this year. During the period from 2010 to 2024 Worldwide Healthcare EBITDA annual values regression line had coefficient of variation of  119.25 and r-squared of  0.03. View All Fundamentals
 
EBITDA  
First Reported
2012-06-30
Previous Quarter
-953 K
Current Value
225.2 M
Quarterly Volatility
45.4 M
 
Yuan Drop
 
Covid
Check Worldwide Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Worldwide Healthcare's main balance sheet or income statement drivers, such as Interest Expense of 8.5 M, Selling General Administrative of 2.8 M or Total Revenue of 218.5 M, as well as many indicators such as . Worldwide financial statements analysis is a perfect complement when working with Worldwide Healthcare Valuation or Volatility modules.
  
This module can also supplement various Worldwide Healthcare Technical models . Check out the analysis of Worldwide Healthcare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Worldwide Stock

Worldwide Healthcare financial ratios help investors to determine whether Worldwide Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Worldwide with respect to the benefits of owning Worldwide Healthcare security.